A Bedside Decision Instrument To Elicit a Patient's Preference Concerning Adjuvant Chemotherapy for Breast Cancer

References

• 1. Bonadonna G and Valagussa P. Adjuvant systemic therapy for resectable breast cancer. J Clin Oncol. 1985;3:259-75. CrossrefMedlineGoogle Scholar
• 2. Henderson C. Adjuvant systemic therapy for early breast cancer. Curr Probl Cancer. 1987;11:125-207. CrossrefMedlineGoogle Scholar
• 3. Fisher B, Redmond C, Dimitrov N, Bowman D, Legault-Poisson S, and Wickerham D. A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors. N Engl J Med. 1989;320:473-8. CrossrefMedlineGoogle Scholar
• 4. Mansour E, Gray R, Shatila A, Osborne C, Tormey D, and Gilchrist K. Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. N Engl J Med. 1989;320:485-90. CrossrefMedlineGoogle Scholar
• 5. . Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer. N Engl J Med. 1989;320:491-6. CrossrefMedlineGoogle Scholar
• 6. McGuire W. Adjuvant therapy of node-negative breast cancer. N Engl J Med. 1989;320:525-7. CrossrefMedlineGoogle Scholar
• 7. Devita V. Breast cancer therapy: exercising all our options [Editorial]. N Engl J Med. 1989;320:527-9. CrossrefMedlineGoogle Scholar
• 8. Levine M, Guyatt G, Gent M, De Pauw S, Goodyear M, and Hryniuk W. Quality of life in stage II breast cancer: an instrument for clinical trials. J Clin Oncol. 1988;6:1798-810. CrossrefMedlineGoogle Scholar
• 9. Hillner B and Smith T. Efficacy and cost-effectiveness of adjuvant chemotherapy in women with node-negative breast cancer. A decision-analysis model. N Engl J Med. 1991;324:160-8. CrossrefMedlineGoogle Scholar
• 10. Rose G. Reflections on the changing times. BMJ. 1990;301:683-7. CrossrefMedlineGoogle Scholar
• 11. Brock D and Wartman S. When competent patients make irrational choices. N Engl J Med. 1990;332:1595-9. CrossrefGoogle Scholar
• 12. Hughes T and Larson L. Patient involvement in health care. A procedural justice viewpoint. Med Care. 1991;29:297-303. CrossrefMedlineGoogle Scholar
• 13. Cassileth B, Zupkis R, Sutton-Smith K, and March V. Information and participation preferences among cancer patients. Ann Intern Med. 1980;92:832-6. LinkGoogle Scholar
• 14. Siminoff L, Fetting J, and Abeloff M. Doctor-patient communication about breast cancer adjuvant therapy. J Clin Oncol. 1989;7:1192-200. CrossrefMedlineGoogle Scholar
• 15. Mackillop W, Stewart W, Ginsburg A, and Stewart S. Cancer patients' perceptions of their disease and its treatment. Br J Cancer. 1988;58:355-8. CrossrefMedlineGoogle Scholar
• 16. O'Connor A, Boyd N, Warde P, Stolbach L, and Till J. Eliciting preferences for alternative drug therapies in oncology: influence of treatment outcome description, elicitation technique and treatment experience on preferences. J Chron Dis. 1987;40:811-8. CrossrefMedlineGoogle Scholar
• 17. Siminoff L and Fetting J. Effects of outcome framing on treatment decisions in the real world: impact of framing on adjuvant breast cancer decisions. Med Decis Making. 1989;9:262-71. CrossrefMedlineGoogle Scholar
• 18. Budescu D and Wallsten T. Dyadic decisions with numerical and verbal probabilities. Organizational Behaviour and Human Decision Processes. 1990;46:240-63. CrossrefGoogle Scholar
• 19. Norman G and Streiner D. PDQ Statistics. Toronto: B.C. Decker Inc.; 1986. Google Scholar
• 20. McGuire W, Tandon A, Allred D, Chamness G, and Clark G. How to use prognostic factors in axillary node-negative breast cancer patients. J Natl Cancer Inst. 1990;82:1006-15. CrossrefMedlineGoogle Scholar
• 21. Levine M, Browman G, Gent M, Roberts R, and Goodyear M. When is a prognostic factor useful? A guide for the perplexed. J Clin Oncol. 1991;9:348-56. CrossrefMedlineGoogle Scholar
• 22. Mehrez A and Gafni A. Quality-adjusted life years (QALYs), utility theory, and healthy-years equivalents. Med Decis Making. 1989;9: 142-9. CrossrefMedlineGoogle Scholar
• 23. Mehrez A and Gafni A. The healthy-years equivalents: how to measure them using the standard gamble approach. Med Decis Making. 1991;11:140-6. CrossrefMedlineGoogle Scholar
• 24. Mehrez A and Gafni A. Evaluating health related quality of life: an indifference curve interpretation for the time trade-off technique. Soc Sci Med. 1990;24:1281-3. CrossrefGoogle Scholar
• 25. Loomes G and MacKenzie L. The use of QALYs in health care decision making. Soc Sci Med. 1989;28:299-308. CrossrefMedlineGoogle Scholar
• 26. Gafni A. Competent patients and irrational choices [Letter]. N Engl J Med. 1990;323:1353-5. CrossrefGoogle Scholar